Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Apr 30 2026
May 21 2026
Mar 18 2025
Dec 19 2025
Oct 11 2025